458 related articles for article (PubMed ID: 17005763)
1. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
[TBL] [Abstract][Full Text] [Related]
2. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
[TBL] [Abstract][Full Text] [Related]
3. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
[TBL] [Abstract][Full Text] [Related]
4. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
[TBL] [Abstract][Full Text] [Related]
5. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
[TBL] [Abstract][Full Text] [Related]
6. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
[TBL] [Abstract][Full Text] [Related]
7. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
[TBL] [Abstract][Full Text] [Related]
8. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
[TBL] [Abstract][Full Text] [Related]
9. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
[TBL] [Abstract][Full Text] [Related]
10. The jejunum of diarrhea-predominant irritable bowel syndrome shows molecular alterations in the tight junction signaling pathway that are associated with mucosal pathobiology and clinical manifestations.
Martínez C; Vicario M; Ramos L; Lobo B; Mosquera JL; Alonso C; Sánchez A; Guilarte M; Antolín M; de Torres I; González-Castro AM; Pigrau M; Saperas E; Azpiroz F; Santos J
Am J Gastroenterol; 2012 May; 107(5):736-46. PubMed ID: 22415197
[TBL] [Abstract][Full Text] [Related]
11. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
[TBL] [Abstract][Full Text] [Related]
12. Peripheral Corticotropin-Releasing Factor Triggers Jejunal Mast Cell Activation and Abdominal Pain in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
Guilarte M; Vicario M; Martínez C; de Torres I; Lobo B; Pigrau M; González-Castro A; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Antolín M; Saperas E; Azpiroz F; Santos J; Alonso-Cotoner C
Am J Gastroenterol; 2020 Dec; 115(12):2047-2059. PubMed ID: 32740086
[TBL] [Abstract][Full Text] [Related]
13. [Associations of sigmoid colon mucosal mast cells with bowel symptoms and psychological status in patients with irritable bowel syndrome with diarrhea].
Xu D; Chen W; Zhou WX; Wang CD; Fei GJ; Zhu LM; Xin HW; Zhong DR; Sun G; Fang XC
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(30):2398-403. PubMed ID: 27545031
[TBL] [Abstract][Full Text] [Related]
14. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
[TBL] [Abstract][Full Text] [Related]
15. Chronological assessment of mast cell-mediated gut dysfunction and mucosal inflammation in a rat model of chronic psychosocial stress.
Vicario M; Guilarte M; Alonso C; Yang P; Martínez C; Ramos L; Lobo B; González A; Guilà M; Pigrau M; Saperas E; Azpiroz F; Santos J
Brain Behav Immun; 2010 Oct; 24(7):1166-75. PubMed ID: 20600818
[TBL] [Abstract][Full Text] [Related]
16. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells.
Vivinus-Nébot M; Dainese R; Anty R; Saint-Paul MC; Nano JL; Gonthier N; Marjoux S; Frin-Mathy G; Bernard G; Hébuterne X; Tran A; Theodorou V; Piche T
Am J Gastroenterol; 2012 Jan; 107(1):75-81. PubMed ID: 21931380
[TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients.
Doyle LA; Sepehr GJ; Hamilton MJ; Akin C; Castells MC; Hornick JL
Am J Surg Pathol; 2014 Jun; 38(6):832-43. PubMed ID: 24618605
[TBL] [Abstract][Full Text] [Related]
18. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
Liu DR; Xu XJ; Yao SK
World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
[TBL] [Abstract][Full Text] [Related]
19. Mast cells count and serum cytokine levels in patients with irritable bowel syndrome.
Goral V; Kucukoner M; Buyukbayram H
Hepatogastroenterology; 2010; 57(101):751-4. PubMed ID: 21033222
[TBL] [Abstract][Full Text] [Related]
20. Nerve growth factor content is increased in the rectal mucosa of children with diarrhea-predominant irritable bowel syndrome.
Willot S; Gauthier C; Patey N; Faure C
Neurogastroenterol Motil; 2012 Aug; 24(8):734-9, e347. PubMed ID: 22625872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
